- Research Article
50
- 10.1016/j.ebiom.2023.104923
Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial
- Dec 14, 2023
- eBioMedicine
- Nicholas C Cullen + 11 more +11